Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Wasatch Micro Cap Fund's investment thesis on TriSalus Life Sciences, Inc. ($TLSI) — Q2 2026 | Buyside Digest

All Pitches

View Letter Analysis

$TLSINASDAQTriSalus Life Sciences, Inc.

NEUTRAL

Wasatch Micro Cap Fund—TLSI

Fund Letter

Q2 2026

Published July 25, 2026

View Fund Profile

$5.23USD

+4.6% vs last month

$4.54Pitched

+15.2% since pitch

Market Cap$287.4M

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

The Wasatch Micro Cap Fund delivered a 27.41% return in Q2 2026, slightly below the Russell Microcap Growth Index's 28.98% gain. Major stock indices...

— Ken Korngiebel, Thomas Bradley, Natalie Pesqué

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $TLSI, and what else Wasatch Micro Cap Fund is buying.

Other pitches on $TLSI

Other investors who've written on TriSalus Life Sciences, Inc.

Micro Cap Fund Commentary 2BEAR

Pitched Jun 30, 2026

The oncology company reported weak revenues and lowered guidance due to organizational restructuring and delayed regulatory approvals for its catheter systems. Additionally, the manager...

View all $TLSI pitches →